Cosciens Biopharma (FRA:ET8) Days Sales Outstanding : 130.63 (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Cosciens Biopharma Days Sales Outstanding?

Cosciens Biopharma's average Accounts Receivable for the three months ended in Mar. 2025 was €1.99 Mil. Cosciens Biopharma's Revenue for the three months ended in Mar. 2025 was €1.39 Mil. Hence, Cosciens Biopharma's Days Sales Outstanding for the three months ended in Mar. 2025 was 130.63.

The historical rank and industry rank for Cosciens Biopharma's Days Sales Outstanding or its related term are showing as below:

FRA:ET8' s Days Sales Outstanding Range Over the Past 10 Years
Min: 14.71 Med: 47.73 Max: 93.67
Current: 69.21

During the past 13 years, Cosciens Biopharma's highest Days Sales Outstanding was 93.67. The lowest was 14.71. And the median was 47.73.

FRA:ET8's Days Sales Outstanding is ranked better than
50.59% of 844 companies
in the Biotechnology industry
Industry Median: 70.135 vs FRA:ET8: 69.21

Cosciens Biopharma's Days Sales Outstanding increased from Mar. 2024 (33.98) to Mar. 2025 (130.63).

Cosciens Biopharma Days Sales Outstanding Historical Data

The historical data trend for Cosciens Biopharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosciens Biopharma Days Sales Outstanding Chart

Cosciens Biopharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

71.60

42.11

45.29

62.08

50.17

Cosciens Biopharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial															33.98	48.19	77.26	56.88	130.63

Competitive Comparison of Cosciens Biopharma's Days Sales Outstanding

For the Biotechnology subindustry, Cosciens Biopharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cosciens Biopharma's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cosciens Biopharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Cosciens Biopharma's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Cosciens Biopharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Cosciens Biopharma's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (0.266	+	2.251)	/	2 )	/	9.156	*	365
=	1.2585					/	9.156	*	365
=	50.17

Cosciens Biopharma's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding (Q: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (2.251	+	1.72)	/	2 )	/	1.387	*	365 / 4
=	1.9855					/	1.387	*	365 / 4
=	130.63

Cosciens Biopharma (FRA:ET8) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Cosciens Biopharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Cosciens Biopharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Cosciens Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cosciens Biopharma Inc (FRA:ET8) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

CSCI:USA ET8:Germany CSCI:Canada

Address

c/o Norton Rose Fulbright Canada LLP, 222 Bay Street, Suite 3000, P.O. Box 53, Toronto, ON, CAN, M5K 1E7

Website

https://www.zentaris.com

Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.

Cosciens Biopharma Headlines

No Headlines